๐ฐ Dimer Binding Assay News
Dimer Binding Assay News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Dimer Binding Assay. Real-time updates on events, politics, business and more.
December 29, 2022
Greenwich LifeSciences, Inc. , a clinical-stage biopharmaceutical company focused on the development of GLSI-100, an immunotherapy to prevent breast cancer recurrences in patients who have... | December 29, 2022
December 1, 2022
Greenwich LifeSciences, Inc. , a clinical-stage biopharmaceutical company focused on the development of GLSI-100, an immunotherapy to prevent breast cancer recurrences in patients who have... | December 1, 2022
August 11, 2022
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on the development of GLSI-100, an immunotherapy to prevent breast cancer recurrences in
December 7, 2021
Press release content from Business Wire. The AP news staff was not involved in its creation.
April 10, 2021
STAFFORD, Texas--(BUSINESS WIRE)--Apr 10, 2021-- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the รขยยCompanyรขยย), a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery, today presented a poster of the final 5 year GP2 Phase IIb clinical trial immune response data at the 2021 AACR Annual Meeting. Immune response is the primary mechanism of action for GP2 and is cr...